Tobramycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 55150-470

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 55150-470). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Tobramycin Fig1)

Figure-1 (Tobramycin Fig1)
Not available.*
FDA Label Image

Package Label.principal Display Panel (1.2 grams per Vial)

Package Label.principal Display Panel (1.2 grams per Vial)
This text appears to be a description of a medication called tobramycin sulfate. Each vial contains 1,200 mg of tobramycin, with the addition of sulfuric acid and/or sodium hydroxide to adjust the pH. The usual dosage and instructions for preparing the solution are provided on the package insert. After reconstitution, the solution should be stored in a refrigerator and used within 96 hours, or within 24 hours if kept at room temperature. The text also mentions that the medication is a pharmacy bulk package and does not contain any preservatives. Prior to reconstitution, it should be stored at controlled room temperature. The medication is intended for intravenous use and should be discarded after a specified date and time. The product is manufactured in India for Eugia US LLC.*
FDA Label Image

Package Label-principal Display Panel (1.2 grams per Vial)

FDA Label Image

Tobramycin-str (Tobramycin Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.